IRAK1 serves as an attractant for development of SLE, and aberrant expression of IRAK1 also promoted the imbalance of the expression level of Th17, and thus has been thought as a biomarker for SLE [22]. The gene discussed is IRAK1; the disease is systemic lupus erythematosus.